Featured Articles Archives - Pharma Journalist

argenx Wins FDA Approval for VYVGART Hytrulo Self-Injection

UPLIZNA Becomes First FDA-Approved Treatment for IgG4-Related Disease

Rilzabrutinib Receives Orphan Drug Designation for Two Rare Diseases

Amneal Launches BORUZU, First Ready-to-Use Bortezomib Injection

Qfitlia Approved as First US Therapy for Hemophilia A/B with or without Inhibitors

Imfinzi Approved as First Perioperative Immunotherapy for Bladder Cancer

Lexicon Pharmaceuticals Signs Exclusive License Agreement with Novo Nordisk for LX9851

Ionis Expands Partnership with Sobi for Olezarsen Commercialization Outside the U.S.

European Commission Approves Merck’s CAPVAXIVE for Pneumococcal Disease in Adults

FDA Grants Fast Track to Chlamydia Vaccine Candidate